Korean Mannyon Pogon Plans Expansion
Jo Kyong Uk, president of the Korean Mannyon Pogon General Trading Corp, a producer and exporter of traditional Korean medicines (Koryo medicines) and medicinal herbs in North Korea, has said that his company is willing to establish joint ventures for the production of Koryo medicines, raw materials and production technology.
The official added that the Korean Mannyon Corp will substantially increase its exports of Koryo raw materials in 1995 from its three Koryo medicine plants and medicinal herb production facilities, according to the Pyongyang Times. It has business contacts with more than 30 trading companies in 20 countries, and hopes to expand the number this year.
Persons interested in following this up should contact Korean Mannyon Pogon General Trading Corp, Othandong, Central District, Pyongyang, DPRK. Fax: +850 2 814410 or +850 2 814546.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze